Latest / Bloomberg Law / Is Settlement in the Cards for Bayer, J&J Lawsuits?
Transcript
- 0:03Speaker 1: Welcome to the Bloomberg Law Podcast. I'm June Grosso. Every
- 0:07Speaker 1: day we bring you insight and analysis into the most
- 0:10Speaker 1: important legal news of the day. You can find more
- 0:13Speaker 1: episodes of the Bloomberg Law Podcast on Apple Podcasts, SoundCloud
- 0:18Speaker 1: and on Bloomberg dot com slash podcasts. J and J
- 0:22Speaker 1: and Buyer are giant companies fighting thousands of lawsuits claiming
- 0:25Speaker 1: that one of their well known products causes cancer. In
- 0:29Speaker 1: J and J's case, that product is its iconic baby powder.
- 0:32Speaker 1: In Buyer's case, that product is its popular round up
- 0:36Speaker 1: weed killer. Is settlement in the cards for either of
- 0:39Speaker 1: those companies? And what would it take? The estimates range
- 0:42Speaker 1: from manageable to colossal. Joining me is Peter Heading, a
- 0:45Speaker 1: professor at Wayne State University Law School. Peter, let's start
- 0:49Speaker 1: with Buyer. Settlement is a one point is it's excuse me?
- 0:52Speaker 1: Settlement is a two point five billion dollar question or
- 0:55Speaker 1: perhaps a twenty billion dollar question, depending on who you ask.
- 0:59Speaker 1: Why is the range so wide? Well, in these mass
- 1:03Speaker 1: torque cases, it's hard to estimate what it's going to
- 1:08Speaker 1: take to settle everything. Of course, Buyer really wants to
- 1:11Speaker 1: see these cases settled. They don't want to get dragged
- 1:15Speaker 1: back into a courtroom where they could face They've already
- 1:18Speaker 1: seen once getting hit with a I think it was
- 1:21Speaker 1: a two billion dollar punitive damage award, and so they
- 1:25Speaker 1: really want to get these resolved. Coming up with a
- 1:28Speaker 1: number that will settle them, though, is difficult, especially when
- 1:32Speaker 1: you have cases filed in state and federal courts. So
- 1:36Speaker 1: just figuring out how to get all of these settled,
- 1:39Speaker 1: if buyer really wants to do that, is you're gonna
- 1:43Speaker 1: have to come up with a number. I suspect it
- 1:45Speaker 1: will be north of two billion dollars. I doubt it
- 1:48Speaker 1: will be twenty billion, but it's going to be in
- 1:52Speaker 1: the billions at least. There's a lot of pressure on
- 1:57Speaker 1: buyer CEO. He was the architect the Monsanto takeover, and
- 2:01Speaker 1: because of the round up debacle, the company has lost
- 2:05Speaker 1: about thirty eight billion dollars in value since buying Montsanto.
- 2:09Speaker 1: Did the market read the costs of the litigation correctly? Um?
- 2:15Speaker 1: I think, at least what the market really does not
- 2:19Speaker 1: like his uncertainty. And so when you're talking about a
- 2:24Speaker 1: range of possible settlements from two billion to twenty billion,
- 2:28Speaker 1: this is what unsettled investors they want certainty. So for buyer,
- 2:35Speaker 1: the key is going to be can they come up
- 2:37Speaker 1: with a dollar figure that is going to resolve these
- 2:41Speaker 1: cases and really just put them behind them? Um. Of course,
- 2:44Speaker 1: the other wild card in all of this, too, is
- 2:47Speaker 1: that cancers take a while to develop, and so even
- 2:52Speaker 1: if they were able to settle every case that's out
- 2:55Speaker 1: there now, they don't know for sure if there are
- 2:57Speaker 1: other ones coming down the pike, and so I suspect
- 3:02Speaker 1: acquiring monsanto um is something that they are going to
- 3:08Speaker 1: regret for a while. Let's turn to J and J now,
- 3:11Speaker 1: with more than fourteen thousand lawsuits over its talent products
- 3:15Speaker 1: over the past three years, jurors have a word a
- 3:18Speaker 1: total of more than five billion to plaintiffs, but some
- 3:21Speaker 1: cases have resulted in hung juries or outright wins for
- 3:24Speaker 1: J and J, and some verdicts have been thrown out
- 3:26Speaker 1: on appeal. Now sources tell Bloomberg that the Justice Department
- 3:30Speaker 1: is pursuing a criminal investigation into whether J and J
- 3:34Speaker 1: lie to the public about the possible cancer risks of
- 3:38Speaker 1: its talcum powder. So a lot of different factors to consider.
- 3:42Speaker 1: How do they play into settlement possibilities. Well, certainly, if
- 3:46Speaker 1: I'm a plaintives attorney, I think I want to see
- 3:50Speaker 1: how the criminal investigation is going to play out. Will
- 3:54Speaker 1: Johnson and Johnson have to, for example, plead guilty um
- 4:00Speaker 1: having made false statements or making maybe perhaps filing false
- 4:04Speaker 1: documents with the government. So at this point, if I'm
- 4:08Speaker 1: a plantiffs attorney, I may want to sit back and
- 4:11Speaker 1: wait and watch to see how this plays out. Because
- 4:15Speaker 1: while Johnson and Johnson disclosed that it had received a
- 4:18Speaker 1: subpoena from the Justice Department, you didn't say it was
- 4:21Speaker 1: a grand jury subpoena, And of course that means that
- 4:24Speaker 1: there is a criminal investigation taking place. So if I'm
- 4:28Speaker 1: a plaintiffs lawyer, I think I want to wait and
- 4:31Speaker 1: watch and see how is this going to play out?
- 4:35Speaker 1: And perhaps I could use any kind of criminal resolution
- 4:39Speaker 1: to my advantage. As far as the criminal investigation, there
- 4:43Speaker 1: is a regulatory investigation already going on, and it's a
- 4:48Speaker 1: it's just a company involved. How how would the penalties differ. Well,
- 4:54Speaker 1: because it's a corporation, so all that can be imposed
- 4:59Speaker 1: on a corporate ration are fines or civil monetary penalties.
- 5:05Speaker 1: But if I'm a plaintiffs lawyer, for example, I want
- 5:09Speaker 1: to see how Johnson and Johnson is going to resolve it.
- 5:13Speaker 1: And if there is a criminal resolution, what's going to
- 5:16Speaker 1: go into what's called the statement of facts, in which
- 5:19Speaker 1: the Justice Department can quite often just dictate the terms
- 5:24Speaker 1: of what a company will agree to. So they are
- 5:28Speaker 1: likely on the hook for some type of penalty, whether
- 5:33Speaker 1: it be civil or criminal. And then of course they
- 5:36Speaker 1: also have all these lawsuits out there that they're going
- 5:39Speaker 1: to have to resolve. They want a few and they've
- 5:41Speaker 1: lost a few. But again, this is where the uncertainty
- 5:45Speaker 1: comes into play. And we've seen today Johnson and Johnson
- 5:49Speaker 1: stock has taken a real hit because of what Bloomberg reported.
- 5:53Speaker 1: And this is again what investors don't like. They don't
- 5:58Speaker 1: like the uncertainty that comes with a criminal investigation. How
- 6:01Speaker 1: will the criminal investigation itself differ from the regulatory investigations. Well,
- 6:08Speaker 1: with a criminal investigation, um, you are the federal prosecutors
- 6:13Speaker 1: can threatened individuals, and indeed the company is expected to
- 6:19Speaker 1: cooperate and if necessary, to offer up individuals who engaged
- 6:26Speaker 1: in wrongdoing. And so that puts enormous pressure on a
- 6:30Speaker 1: company to cooperate, that they have to cooperate. Nobody wants
- 6:35Speaker 1: to appear to be uncooperative, and if they want any
- 6:38Speaker 1: credit for cooperation, they're going to have to offer up
- 6:43Speaker 1: any individuals who might have made either false statements or
- 6:47Speaker 1: misstatements in any kind of public filings or regulatory filings. So, Peter,
- 6:54Speaker 1: there have been turning back to the settlements. J and
- 6:57Speaker 1: Jay's payout could total five to fifteen billion of corps
- 7:00Speaker 1: in Bloomberg Intelligence. That was before news of these criminal investigation.
- 7:06Speaker 1: There have been settlements, huge massive settlements before in bax
- 7:10Speaker 1: In fen Fen. When you look back on them, is
- 7:13Speaker 1: there anything in particular in those cases that moved the
- 7:16Speaker 1: company to settle. Was it a string of you know,
- 7:20Speaker 1: jury losses or jury awards that we're getting bigger, or
- 7:23Speaker 1: just too many plaintiffs. Well, I think part of it
- 7:27Speaker 1: is that, you know, there there is a reputational risk
- 7:30Speaker 1: to a company like Johnson and Johnson. I mean, they
- 7:33Speaker 1: are very much built around and when we've all seen
- 7:36Speaker 1: their ads that you know you can trust us, well
- 7:40Speaker 1: maybe we can't trust them. And so getting these cases
- 7:45Speaker 1: resolved lets them at least put it into the past.
- 7:49Speaker 1: And again at the public has a fairly short memory
- 7:53Speaker 1: for these types of things, and so if they can
- 7:56Speaker 1: get them resolved. Two years from now, some people might
- 8:00Speaker 1: remember Calcolm Powder, but a lot of people are going
- 8:02Speaker 1: to be paying that much attention to it, and you
- 8:05Speaker 1: just move forward. So I think for them, the better
- 8:09Speaker 1: thing is to get them resolved, to put this behind it,
- 8:12Speaker 1: and that gives Wall Street the certainty that it wants
- 8:16Speaker 1: that all right, this is a one time payment. They
- 8:19Speaker 1: made the payment. Now we can move forward. You're so right,
- 8:23Speaker 1: because when I was looking at this, I was going, oh,
- 8:25Speaker 1: fen fen, I forgot about that litigation. Thanks so much, Peter.
- 8:28Speaker 1: As always, that's Peter Henning, Professor at Wayne State University
- 8:32Speaker 1: Law School. Thanks for listening to the Bloomberg Law Podcast.
- 8:38Speaker 1: You can subscribe and listen to the show on Apple podcast, SoundCloud,
- 8:42Speaker 1: and on Bloomberg dot com slash podcast. I'm June Brosso.
- 8:46Speaker 1: This is Bloomberg